These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30759753)

  • 1. Therapeutic Radiometals: Worldwide Scientific Literature Trend Analysis (2008⁻2018).
    Uccelli L; Martini P; Cittanti C; Carnevale A; Missiroli L; Giganti M; Bartolomei M; Boschi A
    Molecules; 2019 Feb; 24(3):. PubMed ID: 30759753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of 11 different radioisotopes for palliative treatment of bone metastases by computational methods.
    Guerra Liberal FD; Tavares AA; Tavares JM
    Med Phys; 2014 Nov; 41(11):114101. PubMed ID: 25370676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Radiometals Beyond
    Müller C; van der Meulen NP; Benešová M; Schibli R
    J Nucl Med; 2017 Sep; 58(Suppl 2):91S-96S. PubMed ID: 28864619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour targeting with radiometals for diagnosis and therapy.
    Ramogida CF; Orvig C
    Chem Commun (Camb); 2013 May; 49(42):4720-39. PubMed ID: 23599005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of novel radionuclides for medical applications.
    Qaim SM; Spahn I
    J Labelled Comp Radiopharm; 2018 Mar; 61(3):126-140. PubMed ID: 29110328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production and Clinical Applications of Radiopharmaceuticals and Medical Radioisotopes in Iran.
    Jalilian AR; Beiki D; Hassanzadeh-Rad A; Eftekhari A; Geramifar P; Eftekhari M
    Semin Nucl Med; 2016 Jul; 46(4):340-58. PubMed ID: 27237443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palliative treatment of metastatic bone pain with radiopharmaceuticals: A perspective beyond Strontium-89 and Samarium-153.
    Guerra Liberal FDC; Tavares AAS; Tavares JMRS
    Appl Radiat Isot; 2016 Apr; 110():87-99. PubMed ID: 26773820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interdisciplinary Tasks in the Cyclotron Production of Radiometals for Medical Applications. The Case of
    Boschi A; Martini P; Costa V; Pagnoni A; Uccelli L
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30691170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Separation of nuclear isomers for cancer therapeutic radionuclides based on nuclear decay after-effects.
    Bhardwaj R; van der Meer A; Das SK; de Bruin M; Gascon J; Wolterbeek HT; Denkova AG; Serra-Crespo P
    Sci Rep; 2017 Mar; 7():44242. PubMed ID: 28287131
    [No Abstract]   [Full Text] [Related]  

  • 10. Re-thinking the role of radiometal isotopes: Towards a future concept for theranostic radiopharmaceuticals.
    Notni J; Wester HJ
    J Labelled Comp Radiopharm; 2018 Mar; 61(3):141-153. PubMed ID: 29143368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin.
    Koppe MJ; Bleichrodt RP; Soede AC; Verhofstad AA; Goldenberg DM; Oyen WJ; Boerman OC
    J Nucl Med; 2004 Jul; 45(7):1224-32. PubMed ID: 15235070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorbed dose profiles for (32)P, (90)Y, (188)Re, (177)Lu, (153)Sm and (169)Er: radionuclides used in radiosynoviortheses treatment.
    Torres M; Ayra E; Albuerne O; Montano Delgado MA
    Rev Esp Med Nucl; 2009; 28(4):188-92. PubMed ID: 19922831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application of radiometallic compounds for medical diagnosis and therapy].
    Saji H
    Yakugaku Zasshi; 2008 Mar; 128(3):323-32. PubMed ID: 18311050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additional hepatic
    Braat AJAT; Kwekkeboom DJ; Kam BLR; Teunissen JJM; de Herder WW; Dreijerink KMA; van Rooij R; Krijger GC; de Jong HWAM; van den Bosch MAAJ; Lam MGEH
    BMC Gastroenterol; 2018 Jun; 18(1):84. PubMed ID: 29902988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matching chelators to radiometals for radiopharmaceuticals.
    Price EW; Orvig C
    Chem Soc Rev; 2014 Jan; 43(1):260-90. PubMed ID: 24173525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting edge rare earth radiometals: prospects for cancer theranostics.
    Sadler AWE; Hogan L; Fraser B; Rendina LM
    EJNMMI Radiopharm Chem; 2022 Aug; 7(1):21. PubMed ID: 36018527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radionuclide treatment of painful bone metastases in patients with breast cancer: a systematic review.
    Christensen MH; Petersen LJ
    Cancer Treat Rev; 2012 Apr; 38(2):164-71. PubMed ID: 21683530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of radionuclide impurities in several radiopharmaceuticals].
    Freudenberg R; Hesse L; Kotzerke J
    Nuklearmedizin; 2022 Aug; 61(4):339-346. PubMed ID: 35426097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoradiotherapy in cancer treatment--basic concepts and future trends.
    Zoller F; Eisenhut M; Haberkorn U; Mier W
    Eur J Pharmacol; 2009 Dec; 625(1-3):55-62. PubMed ID: 19836381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LARAMED: A Laboratory for Radioisotopes of Medical Interest.
    Esposito J; Bettoni D; Boschi A; Calderolla M; Cisternino S; Fiorentini G; Keppel G; Martini P; Maggiore M; Mou L; Pasquali M; Pranovi L; Pupillo G; Rossi Alvarez C; Sarchiapone L; Sciacca G; Skliarova H; Favaron P; Lombardi A; Antonini P; Duatti A
    Molecules; 2018 Dec; 24(1):. PubMed ID: 30577598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.